2022
DOI: 10.3892/etm.2022.11304
|View full text |Cite
|
Sign up to set email alerts
|

Dermoscopy in the diagnosis of cutaneous lymphoma (Review)

Abstract: Cutaneous lymphomas are a group of rare and distinct diseases that present varying clinical manifestations, histopathology and prognosis. Optimal and early management relies on accurate diagnosis. Unfortunately, clinical diagnosis in early stages is difficult due to the clinical overlap with other dermatologic conditions. In numerous cases, several consultations and multiple biopsies are required. Dermoscopy is frequently used for the evaluation of melanocytic skin tumors, but its value has been recognized for… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 30 publications
0
6
0
Order By: Relevance
“…Cutaneous T‐cell lymphomas (CTCL) accounts for around 75%–80% and Cutaneous B‐cell lymphomas (CBCL) represent about 20%–25% of all skin lymphomas. CBCL can be further classified into primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle‐center lymphoma (PCFCL) and primary cutaneous diffuse large B‐cell lymphoma (PCLBCL) 2 . The three entities enumerated comprise 97% of cutaneous B‐cell lymphomas 3 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Cutaneous T‐cell lymphomas (CTCL) accounts for around 75%–80% and Cutaneous B‐cell lymphomas (CBCL) represent about 20%–25% of all skin lymphomas. CBCL can be further classified into primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle‐center lymphoma (PCFCL) and primary cutaneous diffuse large B‐cell lymphoma (PCLBCL) 2 . The three entities enumerated comprise 97% of cutaneous B‐cell lymphomas 3 .…”
Section: Discussionmentioning
confidence: 99%
“…CBCL can be further classified into primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle-center lymphoma (PCFCL) and primary cutaneous diffuse large B-cell lymphoma (PCLBCL). 2 The three entities enumerated comprise 97% of cutaneous B-cell lymphomas. 3 Asian studies usually show lower rates of CBCLs but higher rates of CTCLs compared with Western series.…”
Section: Discussionmentioning
confidence: 99%
“…Clinically, MF typically presents with cutaneous erythematous patches, plaques, tumors, or erythroderma. Nevertheless, atypical variants of MF exist that vary considerably in their clinical and histological features and prognosis: folliculotropic, pagetoid reticulosis, granulomatous slack skin, bullous, hypopigmented, ichthyosiform, pigmented purpuric dermatosis-like, papular, poikilodermatous, psoriasiform, pustular, and verrucoid [ 7 , 8 , 9 , 10 , 11 ]. Consequently, the diagnosis of MF is often difficult and challenging: the differential diagnosis is wide, and the histological findings may be non-specific in the early stages.…”
Section: Photodynamic Therapy and Primary Cutaneous T-cell Lymphomasmentioning
confidence: 99%
“…[19][20][21][22][23][24][25] In human medicine, many studies have been performed to evaluate key dermoscopic features of many diseases. 1,3,6,7,[26][27][28][29][30] Information available from the human literature could be extrapolated to the field of veterinary dermoscopy. Figure 6 shows examples of dermoscopic patterns identified in veterinary patients with neoplastic, inflammatory and noninflammatory dermatological disease.…”
Section: Clinical Applicationsmentioning
confidence: 99%
“…The following diseases have been evaluated with dermoscopy: demodicosis, sarcoptic mange, dermatophytosis, pattern alopecia and alopecia areata 19–25 . In human medicine, many studies have been performed to evaluate key dermoscopic features of many diseases 1,3,6,7,26–30 . Information available from the human literature could be extrapolated to the field of veterinary dermoscopy.…”
Section: Clinical Applicationsmentioning
confidence: 99%